Atripla - a combination of tenofovir (Viread), emtricitabine (Emtriva) and efavirenz (Sustiva)

Atripla works by inhibiting the formation of HIV's genetic material.  Atripla's three components consist of nucleoside (emtricitabine) and nucleotide (tenofovir) reverse transcriptase inhibitors (NRTIs) or nukes and a nonnucleoside reverse transcriptase inhibitor (efavirenz) or non-nuke.

For further information and tips on adherence, go to the Adherence section of this site.

Do not change the dose or timing of Atripla without speaking to your healthcare provider.

If you miss more than one dose, look at the reasons why you missed them and come up with a plan to avoid it in the future.  For example, if you fell asleep too early, take the medicine earlier in the evening, with your later meal, set an alarm, or have someone appointed to wake you up for your medicine.  

It is strongly recommended that you consider using weekly pill boxes and arrange all of your doses a week in advance.  Buy a small pill box so that you can carry a dose or two of your medicines with you in case you are away from home.

Most people take Atripla without many side effects.

Possible side effects include nightmares, restlessness, stimulation, anxiety, depression, insomnia, nausea (which usually gets better over time,) headache, muscle aches, kidney problems, liver problems, allergy or skin discoloration.  Usually you will have blood tests done in the first month to look for the beneficial effects of Atripla and any side effects.   Rarely Atripla can cause kidney problems, usually in persons with underlying kidney disease or people who have lost a lot of weight.  There is also the possibility that Atripla can cause thinning of the bones which might result in bones which break more easily; however, the significance of this is unclear at this time.  Rarely some people notice slight darkening of their palms or soles of the feet.

If someone has never taken efavirenz before, Atripla should be started during a period of time when high alertness and coordination are not required so that the person can adjust to the stimulant side effects.

Many minor side effects will either stay constant or get better with time.  It is mainly the side effects that are severe or get worse that may cause significant health risks for you.

All drugs of this type can cause or contribute to abnormal fat redistribution characterized by thinning of the face, arms, or legs.  In most cases this would be also accompanied by elevated cholesterol levels, elevated triglyceride levels, and perhaps a tendency to develop diabetes.  Atripla may be better than other nukes in this respect.

Rarely, a build-up of (lactic) acid may occur due to taking medications of this type.  Persons taking multiple nukes (NRTIs), those taking d4T (stavudine, Zerit), those on the combination of d4T (stavudine, Zerit) and ddI (didanosine, Videx), and those persons with hepatitis C or other liver diseases are the most likely to encounter this rare, but potentially fatal problem.  Pregnancy may also raise the risk of this problem.  The symptoms are vague but troublesome including increasing fatigue, nausea, vomiting, muscle aches, weakness, turning yellow with jaundice, and just feeling plain bad.  Atripla has very little tendency to cause lactic acidosis.

If you have hepatitis B and you stop Atripla suddenly, your liver may be damaged, possibly severely.  You might even die.

Atripla should not be taken by woman who may become pregnant or woman who are pregnant as birth defects are possible.  More than one form of contraception should be used by women who take Atripla.

Atripla should not be taken with didanosine (Videx EC) unless the dose of didanosine is reduced from normal.

When Atripla is taken with atazanavir (Reyataz), the dose of atazanavir should be changed in most cases to two of the 150 mg atazanavir (Reyataz) capsules and ritonavir (Norvir) boosting with 100 mg per day should be used.